"This was primarily driven by 18% growth seen from the oncology portfolio, which has done well as a result of key drugs such as Imfinzi, Tagrisso and Enhertu. The group shows no sign of slowing down ...

Shares of life sciences company Revvity (NYSE:RVTY) fell 7.6% in the afternoon session after the company lowered its ...

Shares of healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) fell 3.7% in the morning session after the company ...

Sarepta Therapeutics (SRPT) shares dropped sharply on Monday following news that the FDA is investigating a patient death potentially connected to its gene therapy, Elevidys.

Sarepta shares gained even though the U.S. Food and Drug Administration said late Friday that it was probing the death of an ...